James Theiler

EngineeringComputer ScienceMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus”.

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Cell(2020)10.1016/j.cell.2020.06.043

N/A

21.2DataRank · unranked

4474 citations

Will Fischer, S. Gnanakaran, Hyejin Yoon, James Theiler, Werner Abfalterer +34 more

Multiple lineages of monkeypox virus detected in the United States, 2021–2022

Science(2022)10.1126/science.add4153

N/A

13.3DataRank · unranked

280 citations

Bette Korber, Matthew H. Seabolt, Kimberly Wilkins, Whitni Davidson, Agam K. Rao +27 more

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Cell Host & Microbe(2021)10.1016/j.chom.2021.03.002

N/A

10.9DataRank · unranked

395 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +12 more

Defining the risk of SARS-CoV-2 variants on immune protection

Nature(2022)10.1038/s41586-022-04690-5

N/A

4.9DataRank · unranked

185 citations

Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani +95 more

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant

Science Translational Medicine(2022)10.1126/scitranslmed.abm4908

N/A

1.9DataRank · unranked

38 citations

Makoto Kuroda, Tammy Armbrust, James Theiler, Ariane Balaram, Gage K. Moreno +25 more

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.26.505450

N/A

1.0DataRank · unranked

8 citations

Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto +25 more

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428516

N/A

0.657DataRank · unranked

79 citations

Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler +13 more

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.04.556272

N/A

0.538DataRank · unranked

35 citations

Ai‐ris Y. Collier, Nicole P. Hachmann, Jessica Miller, Marjorie Rowe, Eleanor Schonberg +12 more

Real-time monitoring of SARS-CoV-2 evolution during the COVID-19 pandemic

Cell Host & Microbe(2025)10.1016/j.chom.2025.10.013

N/A

0.269DataRank · unranked

5 citations

Will Fischer, James Theiler, Bette Korber

US National Institutes of Health Prioritization of SARS-CoV-2 Variants

Emerging infectious diseases(2023)10.3201/eid2905.221646

N/A

0.208DataRank · unranked

3 citations

Arghavan Alisoltani, Debbie Bratt, Liel Cohen-Lavi, Bethany L. Dearlove, Christian Drosten +29 more

Durable Control of HIV-1 Using a Staphylococcus aureus Cas9-Expressing Lentivirus Co-Targeting Viral Latency and Host Susceptibility

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.10.243329

N/A

0.104DataRank · unranked

1 citations

Nishith R. Reddy, Kyle A. Raymond, Mohamed S. Bouzidi, Shivani Desai, Zain Y. Dossani +5 more

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1

New England Journal of Medicine(2023)10.1056/nejmc2214314

N/A

0DataRank · unranked

242 citations

Nicole P. Hachmann, Ai‐ris Y. Collier, Ninaad Lasrado, Camille R. Mazurek, Robert C. Patio +6 more

Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86

Vaccine(2023)10.1016/j.vaccine.2023.10.051

N/A

0DataRank · unranked

98 citations

Ai‐ris Y. Collier, Nicole P. Hachmann, Jessica Miller, Marjorie Rowe, Eleanor Schonberg +12 more

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens

Cell Host & Microbe(2021)10.1016/j.chom.2021.05.012

N/A

0DataRank · unranked

115 citations

Elena Giorgi, Srirupa Chakraborty, Kien Nguyen, Tanmoy Bhattacharya, James Theiler +51 more

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate

The Lancet Regional Health - Western Pacific(2023)10.1016/j.lanwpc.2023.100777

N/A

0DataRank · unranked

2 citations

Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, Yuko Sakai‐Tagawa +15 more

Durable Control of HIV-1 Using a Staphylococcus aureus Cas9-Expressing Lentivirus Co-Targeting Viral Latency and Host Susceptibility

Research Square(2020)10.21203/rs.3.rs-45582/v1

N/A

0DataRank · unranked

0 citations

Nishith R. Reddy, Kyle A. Raymond, Mohamed S. Bouzidi, Shivani Desai, Zain Y. Dossani +5 more

Mutational basis of serum cross-neutralization profiles elicited by infection or vaccination with SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.13.553144

N/A

0DataRank · unranked

0 citations

Xiaoying Shen, James Theiler, Bethany Girard, Jean‐Claude Marshall, David C. Montefiori +2 more

Substantial Neutralization Escape by the SARS-CoV-2 Omicron Variant BQ.1.1

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.01.514722

N/A

0DataRank · unranked

15 citations

Nicole P. Hachmann, Ai‐ris Y. Collier, Ninaad Lasrado, Camille R. Mazurek, Robert C. Patio +6 more